{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:50:10Z","timestamp":1782708610126,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UT Medical Center"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["4R01DK079984-08"],"award-info":[{"award-number":["4R01DK079984-08"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.antiviral.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,25]],"date-time":"2016-09-25T03:09:28Z","timestamp":1474772968000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in\u00a0vivo and in\u00a0vitro"],"prefix":"10.1016","volume":"135","author":[{"given":"Elisabeth A.","family":"Pitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim E.","family":"Sparer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.09.012_bib1","series-title":"Cytomegalovirus Inter-strain Variance in Cell-type Tropism","author":"Adler","year":"2013"},{"key":"10.1016\/j.antiviral.2016.09.012_bib2","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/JVI.00109-15","article-title":"A\u00a0role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells","volume":"89","author":"Baldwin","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.012_bib4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","article-title":"Heparan sulphate proteoglycans fine-tune mammalian physiology","volume":"446","author":"Bishop","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.012_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01309855","article-title":"Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice","volume":"132","author":"Booth","year":"1993","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib6","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1128\/AAC.00854-13","article-title":"A\u00a0peptide inhibitor of cytomegalovirus infection from human hemofiltrate","volume":"57","author":"Borst","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.012_bib7","first-page":"3499","article-title":"Phage display of combinatorial peptide libraries: application to antiviral research","volume":"16","author":"Castel","year":"2011","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.antiviral.2016.09.012_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00023-08","article-title":"Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention","volume":"22","author":"Cheeran","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.09.012_bib9","first-page":"113","article-title":"Cytomegalovirus infection in patients with HIV infection","volume":"66","author":"Cheung","year":"1999","journal-title":"Mt. Sinai J. Med."},{"key":"10.1016\/j.antiviral.2016.09.012_bib10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.00186-10","article-title":"Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance","volume":"54","author":"Chou","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.012_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcv.2011.01.004","article-title":"Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy","volume":"50","author":"Chou","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.01259-10","article-title":"Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility","volume":"55","author":"Chou","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.012_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/171.3.576","article-title":"Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance","volume":"171","author":"Chou","year":"1995","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/172.1.239","article-title":"Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates","volume":"172","author":"Chou","year":"1995","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib15","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.49.7.2710-2715.2005","article-title":"Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene","volume":"49","author":"Chou","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.012_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1006\/viro.1993.1192","article-title":"Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate","volume":"193","author":"Compton","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.012_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.09.012_bib19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-1033.1989.tb14489.x","article-title":"Cell-surface heparan sulfate and heparan-sulfate\/chondroitin-sulfate hybrid proteoglycans of mouse mammary epithelial cells","volume":"178","author":"David","year":"1989","journal-title":"Eur. J. Biochem. FEBS"},{"key":"10.1016\/j.antiviral.2016.09.012_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib22","doi-asserted-by":"crossref","first-page":"e0126239","DOI":"10.1371\/journal.pone.0126239","article-title":"Novel heparan sulfate-binding peptides for blocking herpesvirus entry","volume":"10","author":"Dogra","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.09.012_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1172\/JCI200113530","article-title":"Molecular diversity of heparan sulfate","volume":"108","author":"Esko","year":"2001","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2016.09.012_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. today"},{"key":"10.1016\/j.antiviral.2016.09.012_bib25","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1128\/JVI.00121-16","article-title":"Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH\/gL\/pUL128L and trimer gH\/gL\/gO as well as antibodies elicited during primary HCMV infection prevent epithelial cell syncytium formation","volume":"90","author":"Gerna","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib26","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial\/epithelial cells, but not fibroblasts, early during primary infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J.\u00a0General Virol."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.antiviral.2016.09.012_bib27","doi-asserted-by":"crossref","first-page":"B197","DOI":"10.1016\/j.vaccine.2012.10.074","article-title":"Desirability and feasibility of a vaccine against cytomegalovirus","volume":"31","author":"Griffiths","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.012_bib28","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1128\/JVI.78.18.10023-10033.2004","article-title":"Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes","volume":"78","author":"Hahn","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archopht.1996.01100140023002","article-title":"Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994","volume":"114","author":"Jabs","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus retinitis and viral resistance: ganciclovir resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib31","doi-asserted-by":"crossref","first-page":"e1004640","DOI":"10.1371\/journal.ppat.1004640","article-title":"Non-redundant and redundant roles of cytomegalovirus gH\/gL complexes in host organ entry and intra-tissue spread","volume":"11","author":"Lemmermann","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.012_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/519941","article-title":"Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients","volume":"45","author":"Li","year":"2007","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.antiviral.2016.09.012_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/342385","article-title":"Ganciclovir-resistant cytomegalovirus in organ transplant recipients","volume":"35","author":"Limaye","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.1026","article-title":"Cell surface heparan sulfate and its roles in assisting viral infections","volume":"22","author":"Liu","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2016.09.012_bib35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/315851","article-title":"Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis","volume":"182","author":"Liu","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib36","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.1208\/aapsj080355","article-title":"Issues related to targeted delivery of proteins and peptides","volume":"8","author":"Lu","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.antiviral.2016.09.012_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/342844","article-title":"Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients","volume":"186","author":"Lurain","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.012_bib38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.09.012_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2013.05.063","article-title":"Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts","volume":"436","author":"Martin","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.09.012_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coph.2008.06.002","article-title":"Discovering and improving novel peptide therapeutics","volume":"8","author":"McGregor","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib41","series-title":"Cytomegaloviruses and Their Replication","author":"Mocarski","year":"1996"},{"key":"10.1016\/j.antiviral.2016.09.012_bib42","series-title":"Fields Virology","first-page":"1960","article-title":"Cytomegaloviruses","author":"Mocarski","year":"2013"},{"key":"10.1016\/j.antiviral.2016.09.012_bib43","first-page":"50","article-title":"Congenital cytomegalovirus infection and hearing loss","volume":"12","author":"Pass","year":"2005","journal-title":"Herpes"},{"key":"10.1016\/j.antiviral.2016.09.012_bib44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1039\/b100916h","article-title":"Heparin and heparan sulfate: structure and function","volume":"19","author":"Rabenstein","year":"2002","journal-title":"Nat. Product. Rep."},{"key":"10.1016\/j.antiviral.2016.09.012_bib45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect. Chemother."},{"key":"10.1016\/j.antiviral.2016.09.012_bib46","doi-asserted-by":"crossref","DOI":"10.3791\/1488","article-title":"Isolation of mouse peritoneal cavity cells","author":"Ray","year":"2010","journal-title":"J.\u00a0Vis. Exp. JoVE"},{"key":"10.1016\/j.antiviral.2016.09.012_bib47","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2016.09.012_bib48","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1073\/pnas.0804365105","article-title":"HCMV gH\/gL\/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors","volume":"105","author":"Ryckman","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.012_bib49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.80.2.710-722.2006","article-title":"Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion","volume":"80","author":"Ryckman","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib50","doi-asserted-by":"crossref","first-page":"501801","DOI":"10.1155\/2013\/501801","article-title":"Cytomegalovirus in the neonate: immune correlates of infection and protection","volume":"2013","author":"Schleiss","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jmv.20150","article-title":"Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations","volume":"74","author":"Scott","year":"2004","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib52","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/JVI.02441-09","article-title":"The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV","volume":"84","author":"Scrivano","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib53","doi-asserted-by":"crossref","first-page":"e1001256","DOI":"10.1371\/journal.ppat.1001256","article-title":"HCMV spread and cell tropism are determined by distinct virus populations","volume":"7","author":"Scrivano","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.012_bib54","series-title":"Mouse Cytomegalovirus and Other Herpesviruses","author":"Shellam","year":"2006"},{"key":"10.1016\/j.antiviral.2016.09.012_bib55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcv.2005.10.014","article-title":"Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies","volume":"35","author":"Singh","year":"2006","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib56","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1099\/vir.0.81595-0","article-title":"Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules","volume":"87","author":"Sinzger","year":"2006","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1586\/erv.10.125","article-title":"Update on the current status of cytomegalovirus vaccines","volume":"9","author":"Sung","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2016.09.012_bib58","doi-asserted-by":"crossref","first-page":"25406","DOI":"10.1074\/jbc.M110.201103","article-title":"Anti-heparan sulfate peptides that block herpes simplex virus infection in\u00a0vivo","volume":"286","author":"Tiwari","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.09.012_bib59","doi-asserted-by":"crossref","first-page":"11638","DOI":"10.1128\/JVI.05659-11","article-title":"Human cytomegalovirus glycoprotein gO complexes with gH\/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells","volume":"85","author":"Vanarsdall","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","article-title":"Human cytomegalovirus entry into cells","volume":"2","author":"Vanarsdall","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2016.09.012_bib61","doi-asserted-by":"crossref","first-page":"e1003493","DOI":"10.1371\/journal.ppat.1003493","article-title":"The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH\/gL\/MCK-2 complex","volume":"9","author":"Wagner","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.09.012_bib62","first-page":"7657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.antiviral.2016.09.012_bib63","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In\u00a0vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2016.09.012_bib64","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.012_bib65","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.1073\/pnas.0709704104","article-title":"Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.09.012_bib66","series-title":"Current Protocols in Immunology","article-title":"The isolation and characterization of murine macrophages","author":"Zhang","year":"2008"},{"key":"10.1016\/j.antiviral.2016.09.012_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinforma."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T07:54:41Z","timestamp":1572422081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421630376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":67,"alternative-id":["S016635421630376X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in\u00a0vivo and in\u00a0vitro","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}